Premium
Primary cutaneous marginal zone lymphoma with sequential development of nodal marginal zone lymphoma in a patient with selective immunoglobulin A deficiency
Author(s) -
Wobser Marion,
Kerstan Andreas,
Kneitz Hermann,
Goebeler Matthias,
Kunzmann Volker,
Rosenwald Andreas,
Geissinger Eva
Publication year - 2013
Publication title -
journal of cutaneous pathology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.597
H-Index - 75
eISSN - 1600-0560
pISSN - 0303-6987
DOI - 10.1111/cup.12230
Subject(s) - marginal zone , nodal , lymphoma , medicine , pathology , splenic marginal zone lymphoma , antibody , marginal zone b cell lymphoma , immunology , b cell
Multiple lymphoma subtypes occurring within one patient is rare in the context of B‐cell lymphoma, and only few such cases have been reported in association with primary cutaneous marginal zone lymphoma ( PCMZL ). We herein describe the case of a 43‐year‐old patient who was diagnosed with PCMZL and subsequently developed a clonally unrelated nodal marginal zone lymphoma ( MZL ). At the time of diagnosis of PCMZL , multiple skin lesions were present. The atypical lymphoid infiltrate showed monotypic expression of immunoglobulin light chain lambda and heavy chain ( IgM ) on immunohistochemistry and an identical B‐cell clone. No sign of systemic lymphoma was present in staging examinations. Complete remission was achieved utilizing rituximab. After a 3‐year clinical course of repetitive cutaneous relapses and remissions, the patient additionally developed nodal lymphoma involvement by MZL which, however, harbored an immunophenotype and a genetic clone distinct from the cutaneous lymphoma counterpart. Therefore, the rare occurrence of two different types of MZL with sequential evolution was diagnosed. In this uncommon case, we hypothesize that selective immunoglobulin A deficiency may play a promoting role for the metachronous development of the two MZL that occurred in our patient.